The TandemHeart system provides up to five liters per minute of blood flow through a cardiac catheterization procedure in as little as 30 minutes. The system is FDA cleared for extracorporeal circulatory support for up to six hours for procedures not requiring full cardiopulmonary bypass.

Fully reimbursed by Medicare under existing DRG codes, the TandemHeart can be placed rapidly in the cath lab or operating room, providing temporary extracorporeal circulatory support.

Exercise Tolerance Testing (ETT) is a diagnostic tool, consisting of the RHE cycle, that is used in conjunction with scientifically validated exercise testing protocols to create a more accurate, sensitive and comfortable test, according to the company.
Quadriceps, hip flexors, gluteus, hamstrings, shoulders, chest, triceps and back can be utilized to complete the revolutions. The high amount of musculature improves mechanical efficiency, allowing the subject to achieve an adequate intensity level while remaining comfortable and minimizing impact on joints.

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for the treatment of carotid artery disease in patients who are at high risk for adverse events from carotid artery surgery. The clearance was supported by the CREATE (Carotid Revascularization with ev3 Inc.

The AtriCure Ablation and Sensing Unit (ASU) is a device that makes linear and transmural lesions in a matter of seconds. The system can demonstrate when a transmural lesion has been formed by measuring the conductance of soft tissue, and it only takes a few seconds by using its patented method of targeting ablative energy.